Thomas Benfield

Also affiliated with Amager Hospital, Hvidovre Hospital, Copenhagen University Hospital

Environmental ScienceBusiness, Management and AccountingHealth ProfessionsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Remdesivir for the Treatment of Covid-19 — Final Report”.

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine(2020)10.1056/nejmoa2007764

N/A

12.3DataRank · unranked

7738 citations

Kay M Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, André C. Kalil +35 more

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Annals of Internal Medicine(2021)10.7326/m21-3507

N/A

3.8DataRank · unranked

76 citations

Jens Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L Holland, Robert L. Gottlieb +88 more

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

The Lancet(2022)10.1016/s0140-6736(22)00101-5

N/A

3.1DataRank · unranked

77 citations

Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu +83 more

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Nature Medicine(2022)10.1038/s41591-022-02023-7

N/A

2.7DataRank · unranked

141 citations

Marie H. Pahus, Míriam Rosás-Umbert, I‐Na Lu, Thomas Benfield, Henrik Nielsen +28 more

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Nature Medicine(2023)10.1038/s41591-023-02547-6

N/A

1.6DataRank · unranked

85 citations

Jesper Falkesgaard Højen, Marie H. Pahus, Míriam Rosás-Umbert, Birgitte Stiksrud, James McMahon +28 more

Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101409

N/A

1.1DataRank · unranked

37 citations

Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter +32 more

Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data

Annals of Internal Medicine(2001)10.7326/0003-4819-135-9-200111060-00008

N/A

0.856DataRank · unranked

299 citations

Philip S. Rosenberg, James J. Goedert, Lesley J. Ashton, Susan P. Buchbinder, Roel A. Coutinho +40 more

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2021)10.1038/s41467-021-22446-z

N/A

0.852DataRank · unranked

292 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2021)10.1038/s41467-021-23559-1

N/A

0.802DataRank · unranked

11 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature Communications(2024)10.1038/s41467-024-45360-6

N/A

0.479DataRank · unranked

9 citations

Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo +100 more